Alps Advisors Inc Eli Lilly & CO Transaction History

Alps Advisors Inc

  • $14.1 Billion
  • Q1 2024

A detailed history of Alps Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Alps Advisors Inc holds 33,321 shares of LLY stock, worth $30.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
33,321
Previous 33,421 0.3%
Holding current value
$30.2 Million
Previous $19.5 Million 33.06%
% of portfolio
0.18%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$592.2 - $792.28 $59,220 - $79,228
-100 Reduced 0.3%
33,321 $25.9 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $69,850 - $82,344
133 Added 0.4%
33,421 $19.5 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $6.73 Million - $9.27 Million
15,471 Added 86.83%
33,288 $17.9 Million
Q2 2023

Aug 14, 2023
SELL
$350.74 - $468.98 $153,273 - $204,944
-437 Reduced 2.39%
17,817 $8.36 Million
Q1 2023

May 10, 2023
SELL
$310.63 - $364.82 $306,281 - $359,712
-986 Reduced 5.12%
18,254 $6.27 Million
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $320,263 - $373,171
-996 Reduced 4.92%
19,240 $7.04 Million
Q3 2022

Nov 14, 2022
SELL
$296.48 - $337.87 $12.3 Million - $14 Million
-41,322 Reduced 67.13%
20,236 $6.54 Million
Q2 2022

Aug 11, 2022
BUY
$278.73 - $327.27 $17.2 Million - $20.1 Million
61,558 New
61,558 $20 Million
Q1 2022

May 16, 2022
SELL
$234.69 - $291.66 $369,871 - $459,656
-1,576 Closed
0 $0
Q4 2021

Feb 09, 2022
SELL
$224.85 - $279.04 $3.41 Million - $4.24 Million
-15,184 Reduced 90.6%
1,576 $435,000
Q3 2021

Nov 15, 2021
SELL
$221.6 - $272.71 $196,559 - $241,893
-887 Reduced 5.03%
16,760 $3.87 Million
Q2 2021

Aug 11, 2021
SELL
$180.55 - $233.54 $137,940 - $178,424
-764 Reduced 4.15%
17,647 $4.05 Million
Q1 2021

May 07, 2021
SELL
$164.32 - $212.72 $459,767 - $595,190
-2,798 Reduced 13.19%
18,411 $3.44 Million
Q4 2020

Feb 03, 2021
SELL
$130.46 - $172.63 $194,254 - $257,046
-1,489 Reduced 6.56%
21,209 $3.58 Million
Q3 2020

Nov 04, 2020
SELL
$146.22 - $169.13 $258,370 - $298,852
-1,767 Reduced 7.22%
22,698 $3.36 Million
Q2 2020

Aug 05, 2020
BUY
$136.42 - $164.18 $401,893 - $483,674
2,946 Added 13.69%
24,465 $4.02 Million
Q1 2020

May 06, 2020
BUY
$119.05 - $147.35 $48,810 - $60,413
410 Added 1.94%
21,519 $2.99 Million
Q4 2019

Feb 07, 2020
SELL
$106.92 - $132.43 $110,020 - $136,270
-1,029 Reduced 4.65%
21,109 $2.78 Million
Q3 2019

Nov 04, 2019
SELL
$106.79 - $116.16 $1.11 Million - $1.21 Million
-10,377 Reduced 31.91%
22,138 $2.48 Million
Q2 2019

Aug 07, 2019
BUY
$110.79 - $129.32 $114,667 - $133,846
1,035 Added 3.29%
32,515 $3.6 Million
Q1 2019

May 01, 2019
SELL
$111.31 - $131.02 $715,389 - $842,065
-6,427 Reduced 16.95%
31,480 $4.09 Million
Q4 2018

Feb 04, 2019
SELL
$105.9 - $118.64 $47.3 Million - $53 Million
-446,632 Reduced 92.18%
37,907 $4.39 Million
Q3 2018

Oct 25, 2018
SELL
$85.86 - $107.31 $7.61 Million - $9.51 Million
-88,646 Reduced 15.47%
484,539 $52 Million
Q2 2018

Aug 02, 2018
BUY
$75.7 - $86.88 $43.4 Million - $49.8 Million
573,185 New
573,185 $48.9 Million
Q2 2018

Jul 25, 2018
SELL
$75.7 - $86.88 $46.3 Million - $53.1 Million
-611,259 Closed
0 $0
Q1 2018

May 01, 2018
BUY
$74.21 - $87.6 $45.4 Million - $53.5 Million
611,259 New
611,259 $47.3 Million
Q4 2017

Feb 05, 2018
SELL
$81.94 - $87.89 $44.8 Million - $48.1 Million
-547,248 Closed
0 $0
Q3 2017

Nov 03, 2017
BUY
$77.07 - $85.54 $42.2 Million - $46.8 Million
547,248
547,248 $46.8 Million

Others Institutions Holding LLY

# of Institutions
3,719
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email